The estimated Net Worth of Thomas W. Dubensky is at least $928 Thousand dollars as of 10 August 2017. Thomas Dubensky owns over 50,000 units of HTG Molecular Diagnostics Inc stock worth over $23,514 and over the last 9 years Thomas sold HTGM stock worth over $904,499.
Thomas has made over 25 trades of the HTG Molecular Diagnostics Inc stock since 2015, according to the Form 4 filled with the SEC. Most recently Thomas exercised 50,000 units of HTGM stock worth $50,000 on 10 August 2017.
The largest trade Thomas's ever made was exercising 144,301 units of HTG Molecular Diagnostics Inc stock on 1 June 2017 worth over $75,037. On average, Thomas trades about 21,420 units every 19 days since 2015. As of 10 August 2017 Thomas still owns at least 48,988 units of HTG Molecular Diagnostics Inc stock.
You can see the complete history of Thomas Dubensky stock trades at the bottom of the page.
Thomas's mailing address filed with the SEC is C/O HTG MOLECULAR DIAGNOSTICS, INC., 3430 E. GLOBAL LOOP, TUCSCON, AZ, 85706.
Over the last 10 years, insiders at HTG Molecular Diagnostics Inc have traded over $5,630,772 worth of HTG Molecular Diagnostics Inc stock and bought 1,019,150 units worth $14,128,765 . The most active insiders traders include Plc Gsk, Holdings A/S Novo, and Laurence W Lytton. On average, HTG Molecular Diagnostics Inc executives and independent directors trade stock every 64 days with the average trade being worth of $28,039. The most recent stock trade was executed by Stephen Barat on 8 June 2023, trading 888 units of HTGM stock currently worth $710.
about htg molecular diagnostics: headquartered in tucson, arizona, htg's mission is to empower precision medicine at the local level. in 2013 the company commercialized its htg edge instrument platform and a portfolio of rna assays that leverage htg's proprietary nuclease protection chemistry. htg's product offerings have since expanded to include its htg edgeseq product line, which automates sample and targeted library preparation for next-generation sequencing. additional information is available at www.htgmolecular.com.
HTG Molecular Diagnostics Inc executives and other stock owners filed with the SEC include: